VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
88,334
AK1,815
AL6,133
AR3,993
AS45
AZ14,539
CA64,759
CO12,159
CT8,719
DC1,747
DE1,868
FL41,499
FM3
GA16,132
GU92
HI2,477
IA4,739
ID2,763
IL21,496
IN23,655
KS4,844
KY8,414
LA5,328
MA15,281
MD13,105
ME3,277
MH8
MI20,143
MN12,873
MO10,275
MP30
MS3,073
MT2,392
NC17,450
ND1,440
NE3,023
NH3,124
NJ19,456
NM4,089
NV4,600
NY36,525
OH20,140
OK6,525
OR8,918
PA24,920
PR2,483
QM2
RI2,092
SC6,952
SD1,243
TN10,038
TX38,745
UT4,482
VA15,477
VI62
VT1,780
WA15,487
WI11,573
WV2,461
WY894
XB5
XL1
XV2

ID: 1600916
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shingles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Not Provided Concomitant information was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1600917
Sex: F
Age: 37
State: NY

Vax Date: 03/27/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: blurred vision; strong headache; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurred vision) and HEADACHE (strong headache) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (blurred vision) and HEADACHE (strong headache). At the time of the report, VISION BLURRED (blurred vision) and HEADACHE (strong headache) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. Concomitant product use was not provided by the reporter. This case was linked to MOD-2021-121772, MOD-2021-121772 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Event outcome updated.

Other Meds:

Current Illness:

ID: 1600918
Sex: F
Age:
State: NJ

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ache/Pain; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache/Pain), FATIGUE (Fatigue) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Ache/Pain), FATIGUE (Fatigue) and PYREXIA (Fever). At the time of the report, PAIN (Ache/Pain), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown. Not Provided Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1600919
Sex: F
Age: 65
State: MD

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in left arm; Tenderness on injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in left arm) and VACCINATION SITE PAIN (Tenderness on injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in left arm) and VACCINATION SITE PAIN (Tenderness on injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Pain in left arm) and VACCINATION SITE PAIN (Tenderness on injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 12-May-2021 contains information regarding the route of Moderna vaccine.

Other Meds:

Current Illness:

ID: 1600920
Sex: F
Age:
State: NJ

Vax Date: 03/12/2021
Onset Date: 03/17/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID positive) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. no medical history was reported by reporter. Concomitant products included METOPROLOL SUCCINATE (TOPROL), HCTZ, VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID positive). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID positive) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, SARS-CoV-2 test: positive (Positive) tested positive for covid. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medicines include Steroid, antibiotic, inhaler

Other Meds: TOPROL; HCTZ; EFFEXOR; SYNTHROID

Current Illness:

ID: 1600921
Sex: F
Age:
State: UT

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: To lay on it was uncomfortable; Sore arm; All her joint hurts; Extreme body ache; A really bad headache with light sensitivity; Fever of 104; Fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache) and HEADACHE (A really bad headache with light sensitivity) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN LISPRO (LISPRO INSULIN), DULOXETINE, DOXYCYCLINE, IRBESARTAN, TRAZODONE, LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN 81), PRAVASTATIN, BIOFLAVONOIDS NOS, VITAMINS NOS (LIPOFLAVONOID [BIOFLAVONOIDS NOS;VITAMINS NOS]), PREGABALIN, CARVEDILOL and VITAMIN D [VITAMIN D NOS] for an unknown indication. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PYREXIA (Fever of 101). On an unknown date, the patient experienced FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache), HEADACHE (A really bad headache with light sensitivity) and PYREXIA (Fever of 104). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache), HEADACHE (A really bad headache with light sensitivity), PYREXIA (Fever of 104) and PYREXIA (Fever of 101) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications and Treatment medications were reported. This case was linked. Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received on 01-jun-2021 and No new information is added

Other Meds: LANTUS; LISPRO INSULIN; DULOXETINE; DOXYCYCLINE; IRBESARTAN; TRAZODONE; LEVOTHYROXINE; ASPIRIN 81; PRAVASTATIN; LIPOFLAVONOID [BIOFLAVONOIDS NOS;VITAMINS NOS]; PREGABALIN; CARVEDILOL; VITAMIN D [VITAMIN D NOS.]

Current Illness:

ID: 1600922
Sex: F
Age: 53
State: CA

Vax Date: 01/16/2021
Onset Date: 02/13/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by an other health care professional and describes the occurrence of DYSPNEA (shortness of breath), COVID-19 (tested positive yesterday with COVID), PAIN (mild body aches), PRODUCTIVE COUGH (productive cough with some green phlegm) and PAIN (severe body aches) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 1097K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (symptoms lasted for 2 weeks) in December 2020. Concomitant products included METFORMIN, DULOXETINE HYDROCHLORIDE (CYMBALTA), GLIPIZIDE and LOSARTAN for an unknown indication. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced PAIN (mild body aches) and PYREXIA (felt feverish and that lasted for one day). On 26-Mar-2021, the patient experienced DYSPNOEA (shortness of breath), PRODUCTIVE COUGH (productive cough with some green phlegm), PAIN (severe body aches), FEELING ABNORMAL (Could not lie flat), DYSPHAGIA (couldn't swallow), DECREASED APPETITE (decrease in appetite), PYREXIA (feeling feverish) and FATIGUE (was in bed all of Saturday and Sunday). On 29-Mar-2021, the patient experienced COVID-19 (tested positive yesterday with COVID). 29-Mar-2021, the patient experienced DIARRHOEA (some diarrhea). 29-Mar-2021, the patient experienced DRUG INEFFECTIVE (lack of drug effect). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (some sore throat today). The patient was treated with IBUPROFEN at a dose of 800 mg and PARACETAMOL (TYLENOL) at a dose of 1000 mg. On 14-Feb-2021, PAIN (mild body aches) and PYREXIA (felt feverish and that lasted for one day) had resolved. On 29-Mar-2021, DRUG INEFFECTIVE (lack of drug effect) outcome was unknown. At the time of the report, DYSPNOEA (shortness of breath), COVID-19 (tested positive yesterday with COVID), PRODUCTIVE COUGH (productive cough with some green phlegm), PAIN (severe body aches), FEELING ABNORMAL (Could not lie flat), DIARRHOEA (some diarrhea), DYSPHAGIA (couldn't swallow), DECREASED APPETITE (decrease in appetite), OROPHARYNGEAL PAIN (some sore throat today), PYREXIA (feeling feverish) and FATIGUE (was in bed all of Saturday and Sunday) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, SARS-CoV-2 test: positive (Positive) positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related. The other events are in consistence with COVID-19. The event of drug ineffective is assessed as possible. Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Upon internal review on 14 Jul 2021, an event (lack of efficacy) was added at Moderna's request.; Sender's Comments: Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related. The other events are in consistence with COVID-19. The event of drug ineffective is assessed as possible.

Other Meds: METFORMIN; CYMBALTA; GLIPIZIDE; LOSARTAN

Current Illness:

ID: 1600923
Sex: F
Age: 61
State: WI

Vax Date: 03/13/2021
Onset Date: 03/13/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID arm; itches randomly; hurting so much, it hurts to the touch/pain; Pain; Hypersensitivity reaction; give the dose a lot lower than where it was given to the spouse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID arm), VACCINATION SITE PRURITUS (itches randomly), VACCINATION SITE PAIN (hurting so much, it hurts to the touch/pain), PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (give the dose a lot lower than where it was given to the spouse) and PAIN (Pain) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concurrent medical conditions included Hay fever, Allergy to molds (Reactions for allergy are sneezing, watery eyes.) since 1970, Allergy to plants (Allergy to trees. Reactions for allergy are sneezing, watery eyes.) since 1970, Allergy to sting (Allergy to bee stings. Reactions for allergy is cellulitis.) since August 2010 and Allergy to antibiotic (Allergy to bactrim) since 2005. Concomitant products included VITAMIN B3, FISH OIL, VITAMIN E NOS (OMEGA 3 [FISH OIL;VITAMIN E NOS]), MULTIVITAMIN & MINERAL, cranberry supplement, CURCUMA LONGA, PIPER NIGRUM (TURMERIC & BLACK PEPPAR) and COLECALCIFEROL (D3) for an unknown indication. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (give the dose a lot lower than where it was given to the spouse). On 20-Mar-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction). On 21-Mar-2021, the patient experienced VACCINATION COMPLICATION (COVID arm), VACCINATION SITE PRURITUS (itches randomly), VACCINATION SITE PAIN (hurting so much, it hurts to the touch/pain) and PAIN (Pain). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (SULFAMETHOXAZOLE AND TRIMETHOPRIM) ongoing since an unknown date for Urinary tract infection, at an unspecified dose and frequency. On 13-Mar-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (give the dose a lot lower than where it was given to the spouse) had resolved. On 31-Mar-2021, HYPERSENSITIVITY (Hypersensitivity reaction) had resolved. At the time of the report, VACCINATION COMPLICATION (COVID arm), VACCINATION SITE PRURITUS (itches randomly), VACCINATION SITE PAIN (hurting so much, it hurts to the touch/pain) and PAIN (Pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient was treated with Benadryl and anti itchy cream. This case was linked to MOD-2021-232309 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow- up received on 23-JUN-2021: Updated patient demographics, medical history, concomitant and treatment medicines. Added event, hypersentivity along with its outcome.

Other Meds: VITAMIN B3; OMEGA 3 [FISH OIL;VITAMIN E NOS]; MULTIVITAMIN & MINERAL; CRANBERRY COMPLEX; TURMERIC & BLACK PEPPAR; D3

Current Illness: Allergy to antibiotic (Allergy to bactrim); Allergy to molds (Reactions for allergy are sneezing, watery eyes.); Allergy to plants (Allergy to trees. Reactions for allergy are sneezing, watery eyes.); Allergy to sting (Allergy to bee stings. Reactions for allergy is cellulitis.); Hay fever

ID: 1600924
Sex: F
Age: 76
State: NY

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chest; flu; back pain; chills; muscle ache; headache; little bit tired/ fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest), INFLUENZA (flu), BACK PAIN (back pain), CHILLS (chills) and MYALGIA (muscle ache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included CHOLESTEROL for an unknown indication. On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced CHEST DISCOMFORT (Chest), INFLUENZA (flu), BACK PAIN (back pain), CHILLS (chills), MYALGIA (muscle ache), HEADACHE (headache) and FATIGUE (little bit tired/ fatigue). At the time of the report, CHEST DISCOMFORT (Chest), INFLUENZA (flu), BACK PAIN (back pain), CHILLS (chills), MYALGIA (muscle ache), HEADACHE (headache) and FATIGUE (little bit tired/ fatigue) outcome was unknown. Treatment information not provided. Other Concomitant medications included Anticancer medications. This case was linked to MOD21-065571 (E2B Linked Report). This case was linked to MOD-2021-062208 (Patient Link).; Sender's Comments: MOD21-065571:Link to Dose 2 with argus ID MOD-2021-062208

Other Meds: CHOLESTEROL

Current Illness:

ID: 1600925
Sex: M
Age: 38
State: MD

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in left arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in left arm) and HEADACHE (headache) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in left arm) and HEADACHE (headache). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 UNK. On 28-Feb-2021, PAIN IN EXTREMITY (pain in left arm) and HEADACHE (headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1600926
Sex: M
Age:
State: UT

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bad case of sciatica pain; sciatica pain focused on back; This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (bad case of sciatica pain) and BACK PAIN (sciatica pain focused on back) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SCIATICA (bad case of sciatica pain) and BACK PAIN (sciatica pain focused on back). The patient was treated with IBUPROFEN ongoing since an unknown date for Sciatica, at a dose of 1 dosage form and CORTISONE ongoing since an unknown date for Sciatica, at a dose of 1 dosage form. At the time of the report, SCIATICA (bad case of sciatica pain) and BACK PAIN (sciatica pain focused on back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product information was not provided. Consumer reported mild relief with treatment of ibuprofen. Consumer visited a chiropractor on unknown date, and described receiving "like a cortisone injection." Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Vaccination site discomfort was removed from adverse events. Consumer report of "like a cortisone injection" was referring to a treatment only. On 27-Jul-2021: Patient demographics updated.

Other Meds:

Current Illness:

ID: 1600927
Sex: M
Age: 72
State: FL

Vax Date: 02/27/2021
Onset Date: 03/28/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: coldness; Sleepy; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (coldness), SOMNOLENCE (Sleepy) and FATIGUE (fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. Concomitant products included ATENOLOL, CLONAZEPAM, CITALOPRAM, FINASTERIDE, TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF), VITAMIN B12 [VITAMIN B12 NOS] and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced FEELING COLD (coldness), SOMNOLENCE (Sleepy) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING COLD (coldness), SOMNOLENCE (Sleepy) and FATIGUE (fatigue) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: ATENOLOL; CLONAZEPAM; CITALOPRAM; FINASTERIDE; FLOMAX RELIEF; VITAMIN B12 [VITAMIN B12 NOS]; ASPIRIN (E.C.)

Current Illness:

ID: 1600928
Sex: F
Age:
State: NY

Vax Date: 03/05/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling; a little rash on right arm; rash on left arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), RASH (a little rash on right arm), RASH (rash on left arm) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Allergy to vaccine. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), RASH (a little rash on right arm), RASH (rash on left arm) and HEADACHE (headache). At the time of the report, SWELLING (swelling), RASH (a little rash on right arm), RASH (rash on left arm) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.No treatment information was provided.

Other Meds:

Current Illness: Allergy to vaccine

ID: 1600929
Sex: M
Age: 76
State: TN

Vax Date: 03/01/2021
Onset Date: 03/29/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 022m20A) for COVID-19 vaccination. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with MEFENAMIC ACID (ADVIL [MEFENAMIC ACID]) in March 2021 for Pain in arm, at a dose of UNK dosage form. On 30-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: not provided Not provided. Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26 May 2021 had updated address of reporter, additional information of patient, current condition of patient concomitant medication patient used to take, information regarding first dose of vaccine and vaccine facility, event outcome and stop date.

Other Meds: LIPITOR

Current Illness:

ID: 1600930
Sex: M
Age: 75
State: SC

Vax Date: 03/19/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bones aching; dizzy; no kind of energy; a slight headache; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache) and CHILLS (Chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant information provided. No Treatment information provided.

Other Meds:

Current Illness:

ID: 1600931
Sex: F
Age:
State: TX

Vax Date: 02/26/2021
Onset Date: 03/28/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: achy; feverish; could hardly breathe good; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could hardly breathe good), MYALGIA (achy) and PYREXIA (feverish) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 040A21A) for COVID-19 vaccination. The patient's past medical history included Asthma and Allergy. Concomitant products included LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced DYSPNOEA (could hardly breathe good). On an unknown date, the patient experienced MYALGIA (achy) and PYREXIA (feverish). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (could hardly breathe good) had resolved and MYALGIA (achy) and PYREXIA (feverish) had not resolved. Treatment medications taken were antibiotics Action taken with mRNA-1273 in response to the events were Not Applicable

Other Meds: XOPENEX

Current Illness:

ID: 1600932
Sex: M
Age: 73
State: MI

Vax Date: 03/02/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Don't know how much it got but a lot was on the arm; When pushing the dose more come out of the syringe, felt like the dose was coming out from; Don't know how much it got but a lot was on the arm; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPOSURE VIA SKIN CONTACT (Don't know how much it got but a lot was on the arm), DEVICE CONNECTION ISSUE (When pushing the dose more come out of the syringe, felt like the dose was coming out from) and INCORRECT DOSE ADMINISTERED (Don't know how much it got but a lot was on the arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 025A21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced EXPOSURE VIA SKIN CONTACT (Don't know how much it got but a lot was on the arm), DEVICE CONNECTION ISSUE (When pushing the dose more come out of the syringe, felt like the dose was coming out from) and INCORRECT DOSE ADMINISTERED (Don't know how much it got but a lot was on the arm). On 30-Mar-2021, EXPOSURE VIA SKIN CONTACT (Don't know how much it got but a lot was on the arm), DEVICE CONNECTION ISSUE (When pushing the dose more come out of the syringe, felt like the dose was coming out from) and INCORRECT DOSE ADMINISTERED (Don't know how much it got but a lot was on the arm) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. On 02 march 2021 the patient received the first of the two planned doses of mRNA - 1273 (Lot no: 025A21A, Exp date: 8 /24/20 21) via intramuscular route on Left arm. Treatment information not provided. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1600933
Sex: F
Age: 64
State: VA

Vax Date: 03/22/2021
Onset Date: 03/23/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Little bit itchiness; Solid about the size of 50 cents; Swelling on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling on the left arm), PRURITUS (Little bit itchiness) and INJECTION SITE INDURATION (Solid about the size of 50 cents) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) for an unknown indication. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling on the left arm). On 30-Mar-2021, the patient experienced PRURITUS (Little bit itchiness) and INJECTION SITE INDURATION (Solid about the size of 50 cents). At the time of the report, PERIPHERAL SWELLING (Swelling on the left arm), PRURITUS (Little bit itchiness) and INJECTION SITE INDURATION (Solid about the size of 50 cents) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments. The patient developed swelling on the left arm one week post receiving the first dose. Initially there was a small reaction of swelling on next day, but it was subsided. On 30-Mar-2021, the swelling reappeared about the size of 50 cents and it was solid associated with little itchiness. No treatment information was provided.

Other Meds: PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]

Current Illness:

ID: 1600934
Sex: M
Age: 19
State: GA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Both arms were hurting; Patient received two vaccines in one day (left and right arm); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ACCIDENTAL OVERDOSE (Patient received two vaccines in one day (left and right arm)) and VACCINATION SITE PAIN (Both arms were hurting) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 003A21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (Patient received two vaccines in one day (left and right arm)). On an unknown date, the patient experienced VACCINATION SITE PAIN (Both arms were hurting). On 24-Mar-2021, ACCIDENTAL OVERDOSE (Patient received two vaccines in one day (left and right arm)) had resolved. At the time of the report, VACCINATION SITE PAIN (Both arms were hurting) outcome was unknown. The patient reported that they received both their Moderna vaccines on 24-MAR-2021. Reportedly, the patient received one shot in their left arm and one shot in the right arm by the same Pharmacist. The patient also stated that they didn't know that the patient was only supposed to receive one shot. The Pharmacy also advised the patient to come back for their 3rd shot. The patient also went to emergency room because both their arms were hurting. No Concomitant product use was reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.

Other Meds:

Current Illness:

ID: 1600935
Sex: F
Age: 57
State: NM

Vax Date: 03/30/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Administered 1ml to five patients; This spontaneous case was reported by a nurse and describes the occurrence of OVERDOSE (Administered 1ml to five patients) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On an unknown date, the patient experienced OVERDOSE (Administered 1ml to five patients). At the time of the report, OVERDOSE (Administered 1ml to five patients) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The reporter was a Nurse who reported that they administered 1 ml to five patients on 30-Mar-2021 . The patients were monitored, and nurse planned to inform the patients that they received 1ml. No Concomitant product use was reported. No treatment information was provided. This case was linked to MOD-2021-062195 (Patient Link).

Other Meds:

Current Illness:

ID: 1600936
Sex: F
Age: 60
State: TX

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Whole body became sweaty; Gets cold; Feels miserable; Nausea; Vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Whole body became sweaty), NASOPHARYNGITIS (Gets cold), FEELING ABNORMAL (Feels miserable), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No Significant medical history). On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced HYPERHIDROSIS (Whole body became sweaty), NASOPHARYNGITIS (Gets cold), FEELING ABNORMAL (Feels miserable), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). At the time of the report, HYPERHIDROSIS (Whole body became sweaty), NASOPHARYNGITIS (Gets cold), FEELING ABNORMAL (Feels miserable), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medicines include Extra Strength Tylenol

Other Meds:

Current Illness:

ID: 1600937
Sex: F
Age: 69
State: KS

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness on injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 043L20A) for COVID-19 vaccination. Concurrent medical conditions included Gout. Concomitant products included DIAZEPAM (VALIUM) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness on injection site). At the time of the report, VACCINATION SITE PAIN (Soreness on injection site) had resolved. The patient with preexisting medical conditions on 24-Feb-2021 received their second dose and reported of having experienced soreness on the injection site similar symptoms, with same onset and remission that they experienced post receiving their first dose of vaccine. The patient had their first dose of Moderna COVID-19 vaccine on 27-Jan-2021 and experienced soreness on the injection site on the following day, which resolved in the span of approximately one day. Concomitant medications reported by the patient also included gout medication and muscle relaxants. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable This case was linked to MOD-2021-064955 (Patient Link).

Other Meds: VALIUM

Current Illness: Gout

ID: 1600938
Sex: M
Age: 43
State: MI

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ringing in my ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in my ears) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. Concurrent medical conditions included Asthma and Cholesterol. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), ROSUVASTATIN, FLECAINIDE and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced TINNITUS (Ringing in my ears). At the time of the report, TINNITUS (Ringing in my ears) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient who received their first dose of the Moderna COVID-19 vaccine reported that within an hour, they could hear ringing in their ears. The patient reports that it got louder and was worse and stated they had this condition before. The patient had an appointment with their doctor on 31-Mar-2021. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow Up received contains No new Information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: ADVAIR; ROSUVASTATIN; FLECAINIDE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness: Asthma; Cholesterol

ID: 1600939
Sex: F
Age: 74
State: IN

Vax Date: 01/20/2021
Onset Date: 03/26/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Increased blood pressure; Get tired after Meals; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Increased blood pressure) and FATIGUE (Get tired after Meals) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. Concurrent medical conditions included Acid reflux (esophageal). On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (Increased blood pressure) and FATIGUE (Get tired after Meals). At the time of the report, BLOOD PRESSURE INCREASED (Increased blood pressure) and FATIGUE (Get tired after Meals) outcome was unknown. The patient received their first dose of vaccine on 20-Jan-2021 and second dose on 18-Feb-2021. The patient did not have any side effects after both doses of the vaccine but during conversation, the patient reported possible adverse events and stated that the patient began to experience increased blood pressure and get tired after meals and these possible adverse events started on 26-Mar-2021. Reportedly, the patient had a past history of acid reflux and was taking medication for it. On 30-Mar-2021, the patient would be going to urgent care to get evaluated. Concomitant medication included medication for acid reflux. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.

Other Meds:

Current Illness: Acid reflux (esophageal)

ID: 1600940
Sex: F
Age: 80
State: NY

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diarrhea; cough; phlegm; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PAIN IN EXTREMITY (Sore arm), COUGH (cough) and PRODUCTIVE COUGH (phlegm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Previously administered products included for an unreported indication: FLU. Concurrent medical conditions included Flu vaccination. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 08-Mar-2021, the patient experienced DIARRHOEA (diarrhea), COUGH (cough) and PRODUCTIVE COUGH (phlegm). On 10-Mar-2021, DIARRHOEA (diarrhea), PAIN IN EXTREMITY (Sore arm), COUGH (cough) and PRODUCTIVE COUGH (phlegm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Treatment information was not reported. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: The patient stated that she got both the shots of vaccine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Flu vaccination

ID: 1600941
Sex: F
Age: 47
State: NJ

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sharp pain; the episodes repeat as the medication wears off; allergic reaction; sharp pain and numbness on the arms and legs; numbness on arms and legs; headache; palpitations; dizziness; Very very shaken; Tingling on the face and jaws; fuzzy; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), DIZZINESS (dizziness), TREMOR (Very very shaken), PARAESTHESIA (Tingling on the face and jaws) and FEELING ABNORMAL (fuzzy) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Shellfish allergy and Penicillin allergy. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PALPITATIONS (palpitations), DIZZINESS (dizziness), TREMOR (Very very shaken), PARAESTHESIA (Tingling on the face and jaws), FEELING ABNORMAL (fuzzy), PAIN IN EXTREMITY (sharp pain and numbness on the arms and legs), HYPOAESTHESIA (numbness on arms and legs) and HEADACHE (headache). On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction), PAIN (sharp pain) and VACCINATION COMPLICATION (the episodes repeat as the medication wears off). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 mg and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PALPITATIONS (palpitations), DIZZINESS (dizziness), TREMOR (Very very shaken), PARAESTHESIA (Tingling on the face and jaws), FEELING ABNORMAL (fuzzy), HYPERSENSITIVITY (allergic reaction), PAIN IN EXTREMITY (sharp pain and numbness on the arms and legs), PAIN (sharp pain), VACCINATION COMPLICATION (the episodes repeat as the medication wears off), HYPOAESTHESIA (numbness on arms and legs) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant products were not provided. Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Non-Significant follow up received on 18-May-2021. Contact information updated.

Other Meds:

Current Illness: Penicillin allergy; Shellfish allergy

ID: 1600942
Sex: F
Age: 44
State: CT

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy; Hard to touch; Warm to touch; Injection site is red; Injection site is swollen; Sore arm; Lymph node swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PRURITUS (Itchy), VACCINATION SITE MASS (Hard to touch), VACCINATION SITE WARMTH (Warm to touch) and LYMPHADENOPATHY (Lymph node swollen) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Anxiety, Asthma and ADHD. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and LYMPHADENOPATHY (Lymph node swollen). On 29-Mar-2021, the patient experienced PRURITUS (Itchy), VACCINATION SITE MASS (Hard to touch), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is swollen). On 22-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 26-Mar-2021, LYMPHADENOPATHY (Lymph node swollen) had resolved. At the time of the report, PRURITUS (Itchy), VACCINATION SITE MASS (Hard to touch), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient received their 1st dose of Moderna vaccine on 18-Mar-2021 and on same day the patient began to have sore arm and it went away on 22-Mar-2021. The patient also reported that their lymph node was swollen as well and went away probably on 26-Mar-2021. On 29-Mar-2021, the patient noticed that their injection site was red, swollen, hard to touch, warm to touch and itchy as well. Concomitant medications included anxiety medication, asthma medication and ADHD medication. No treatment information was provided.

Other Meds:

Current Illness: ADHD; Anxiety; Asthma

ID: 1600943
Sex: F
Age: 56
State: SC

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in right side neck; Swelling on right arm; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain in right side neck), PERIPHERAL SWELLING (Swelling on right arm) and VACCINATION SITE PAIN (Vaccination site pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure management. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced NECK PAIN (Pain in right side neck), PERIPHERAL SWELLING (Swelling on right arm) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, NECK PAIN (Pain in right side neck), PERIPHERAL SWELLING (Swelling on right arm) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. concomitant medication included blood pressure pill. Treatment medication included Tylenol. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: TCR attached 12 MAY 2021 and its NNI.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Blood pressure management

ID: 1600944
Sex: U
Age: 68
State: MI

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash in Upper Body, upper extremities, back, chest, and stomach; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in Upper Body, upper extremities, back, chest, and stomach) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced RASH (Rash in Upper Body, upper extremities, back, chest, and stomach). At the time of the report, RASH (Rash in Upper Body, upper extremities, back, chest, and stomach) outcome was unknown. Not Provided concomitant medications are not provided. No treatment information was provided. Action taken in response to mRNA-1273 was not applicable.

Other Meds:

Current Illness:

ID: 1600945
Sex: F
Age:
State: NC

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very sore arm for a long time; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very sore arm for a long time) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Very sore arm for a long time). At the time of the report, PAIN IN EXTREMITY (Very sore arm for a long time) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient received their first dose of Moderna vaccine 03-Mar-2021 and experienced a very sore arm for a long time. No Concomitant product use was reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1600946
Sex: F
Age: 70
State: AL

Vax Date: 03/16/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (rash on the arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (rash on the arm). At the time of the report, VACCINATION SITE ERYTHEMA (rash on the arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. She took cholesterol pills. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: NNI; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: VITAMINS A & D.

Current Illness:

ID: 1600947
Sex: M
Age:
State: PA

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experienced sore arm after the 2nd dose of moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (experienced sore arm after the 2nd dose of moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (experienced sore arm after the 2nd dose of moderna vaccine). At the time of the report, PAIN IN EXTREMITY (experienced sore arm after the 2nd dose of moderna vaccine) outcome was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1600948
Sex: F
Age: 53
State: CT

Vax Date: 03/18/2021
Onset Date: 03/26/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Upper arm area swollen; Upper arm area was itchy; Covid arm; Hard circle at injection site that feels hot to the touch; Upper arm area was sore; Large, raised, hard circle at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Upper arm area swollen), PRURITUS (Upper arm area was itchy), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE WARMTH (Hard circle at injection site that feels hot to the touch) and PAIN IN EXTREMITY (Upper arm area was sore) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B211A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PERIPHERAL SWELLING (Upper arm area swollen), PRURITUS (Upper arm area was itchy), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE WARMTH (Hard circle at injection site that feels hot to the touch), PAIN IN EXTREMITY (Upper arm area was sore) and VACCINATION SITE INDURATION (Large, raised, hard circle at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Product used for unknown indication, at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (Upper arm area swollen), PRURITUS (Upper arm area was itchy), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE WARMTH (Hard circle at injection site that feels hot to the touch), PAIN IN EXTREMITY (Upper arm area was sore) and VACCINATION SITE INDURATION (Large, raised, hard circle at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient post receiving their first dose reported Covid arm and having a large, raised, hard circle at injection site that felt hot to the touch. The upper arm area was swollen, itchy and sore. Reportedly, symptoms started eight days after the vaccine on 26-Mar-21 and the patient thought it was a spider bite until going to the doctor. The patient was put on a topical steroid and Benadryl. On 30-Mar-2021 at the time of reporting, the patient stated that it was not completely gone but getting better. No Concomitant product use was reported. Treatment medication included topical steroid and Benadryl. Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Non-Significant follow up appended: Contact information updated

Other Meds:

Current Illness:

ID: 1600949
Sex: F
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills that lasted one day.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced CHILLS (Chills that lasted one day.). On 20-Jan-2021, CHILLS (Chills that lasted one day.) had resolved. Not Provided. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant and treatment medications were reported. Treatment information provided included none. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1600950
Sex: M
Age:
State: IL

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe arm pain; Fatigue similar to when he had COVID; Arm started to hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started to hurt), PAIN IN EXTREMITY (Severe arm pain) and FATIGUE (Fatigue similar to when he had COVID) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The patient's past medical history included COVID-19. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm started to hurt). On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (Severe arm pain) and FATIGUE (Fatigue similar to when he had COVID). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm started to hurt), PAIN IN EXTREMITY (Severe arm pain) and FATIGUE (Fatigue similar to when he had COVID) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1600951
Sex: F
Age:
State: TN

Vax Date: 03/19/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness in my arm; Hot to the touch; Redness at the injection site; Really painfully sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in my arm), VACCINATION SITE WARMTH (Hot to the touch), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PAIN (Really painfully sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC), ROSUVASTATIN CALCIUM (CRESTOR), TAMOXIFEN and VITAMIN D3 for an unknown indication. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PAIN (Really painfully sore). On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in my arm). At the time of the report, PAIN IN EXTREMITY (Soreness in my arm), VACCINATION SITE WARMTH (Hot to the touch), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PAIN (Really painfully sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medications were reported.

Other Meds: PROZAC; CRESTOR; TAMOXIFEN; VITAMIN D3

Current Illness:

ID: 1600952
Sex: F
Age: 30
State: TX

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lump at the injection site; it is swollen at the injection site; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at the injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (it is swollen at the injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). On 30-Mar-2021, the patient experienced VACCINATION SITE MASS (lump at the injection site) and VACCINATION SITE SWELLING (it is swollen at the injection site). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 30-Mar-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (lump at the injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (it is swollen at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1600953
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; body ache severe; headache; arm left pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), PAIN (body ache severe), HEADACHE (headache) and PAIN IN EXTREMITY (arm left pain) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included PROLIFE for Asthma, ASCORBIC ACID (C VITAMIN), VITAMIN D3, ZINC and VITAMIN B COMPLEX for an unknown indication. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue), PAIN (body ache severe), HEADACHE (headache) and PAIN IN EXTREMITY (arm left pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FATIGUE (fatigue), PAIN (body ache severe), HEADACHE (headache) and PAIN IN EXTREMITY (arm left pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications, Allergy medication Vitamin C, Vitamin D3,Zinc,Vitamin B complex,Prolife (medication for asthma).

Other Meds: C VITAMIN; VITAMIN D3; ZINC; VITAMIN B COMPLEX; PROLIFE

Current Illness:

ID: 1600954
Sex: F
Age:
State:

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Arm pain; Unable to lift arm; Fever of 99.9 F; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Arm pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to lift arm), PYREXIA (Fever of 99.9 F) and VOMITING (Vomiting) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Arm pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to lift arm), PYREXIA (Fever of 99.9 F) and VOMITING (Vomiting). On 20-Mar-2021, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever of 99.9 F) and VOMITING (Vomiting) had resolved. On 22-Mar-2021, VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to lift arm) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: 99.9 (Inconclusive) 99.9 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds: TYLENOL

Current Illness:

ID: 1600955
Sex: F
Age: 68
State: KY

Vax Date: 02/24/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy hot rash on injection site uptil elbow; hot to touch rash on injection site which is extended uptil her elbow; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy hot rash on injection site uptil elbow) and VACCINATION SITE WARMTH (hot to touch rash on injection site which is extended uptil her elbow) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced VACCINATION SITE WARMTH (hot to touch rash on injection site which is extended uptil her elbow). On 30-Mar-2021, the patient experienced RASH PRURITIC (Itchy hot rash on injection site uptil elbow). At the time of the report, RASH PRURITIC (Itchy hot rash on injection site uptil elbow) and VACCINATION SITE WARMTH (hot to touch rash on injection site which is extended uptil her elbow) outcome was unknown. Not Provided No relevant concomitant medication was reported. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not Applicable.

Other Meds:

Current Illness:

ID: 1600956
Sex: M
Age: 63
State: FL

Vax Date: 02/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cold; felt extreme fatigue; body ache mainly in joints; body ache mainly in joints; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), FATIGUE (felt extreme fatigue), MYALGIA (body ache mainly in joints) and ARTHRALGIA (body ache mainly in joints) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), FATIGUE (felt extreme fatigue), MYALGIA (body ache mainly in joints) and ARTHRALGIA (body ache mainly in joints). At the time of the report, NASOPHARYNGITIS (cold), FATIGUE (felt extreme fatigue), MYALGIA (body ache mainly in joints) and ARTHRALGIA (body ache mainly in joints) had not resolved. No concomitant and treatment medicine has been reported by reporter. Action taken with mRNA-1273 in response to the events was not Applicable.

Other Meds:

Current Illness:

ID: 1600957
Sex: F
Age: 71
State: NC

Vax Date: 03/12/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bruise on injection site; Face was really red.; Rapid heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Rapid heartbeat), INJECTION SITE BRUISING (Bruise on injection site) and ERYTHEMA (Face was really red.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Rapid heartbeat), INJECTION SITE BRUISING (Bruise on injection site) and ERYTHEMA (Face was really red.). At the time of the report, PALPITATIONS (Rapid heartbeat), INJECTION SITE BRUISING (Bruise on injection site) and ERYTHEMA (Face was really red.) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 120 (High) 120bpm. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1600958
Sex: M
Age:
State: NJ

Vax Date:
Onset Date: 03/22/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Some type of numbness on left side of face to leg/numbness in left foot and left side of leg, face, and arm; Heat on left side of face to leg; Pain in left foot and left side of leg, face, and arm; Tired; Headache; Pain in left foot and left side of leg, face, and arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Some type of numbness on left side of face to leg/numbness in left foot and left side of leg, face, and arm), FEELING HOT (Heat on left side of face to leg), FACIAL PAIN (Pain in left foot and left side of leg, face, and arm), PAIN IN EXTREMITY (Pain in left foot and left side of leg, face, and arm) and FATIGUE (Tired) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Blood cholesterol abnormal. Concomitant products included SIMVASTATIN (STATIN [SIMVASTATIN]) for Blood cholesterol abnormal. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in left foot and left side of leg, face, and arm). On an unknown date, the patient experienced HYPOAESTHESIA (Some type of numbness on left side of face to leg/numbness in left foot and left side of leg, face, and arm), FEELING HOT (Heat on left side of face to leg), FACIAL PAIN (Pain in left foot and left side of leg, face, and arm), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, HYPOAESTHESIA (Some type of numbness on left side of face to leg/numbness in left foot and left side of leg, face, and arm), FEELING HOT (Heat on left side of face to leg), FACIAL PAIN (Pain in left foot and left side of leg, face, and arm), PAIN IN EXTREMITY (Pain in left foot and left side of leg, face, and arm), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medication use was provided by the reporter.

Other Meds: STATIN [SIMVASTATIN]

Current Illness:

ID: 1600959
Sex: M
Age: 59
State: FL

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nausea) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Diagnosed with COVID-19) in November 2020. On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient post receiving their first dose of vaccine reported of having chills, fever, headache, and nausea. No Concomitant product use was reported.

Other Meds:

Current Illness:

ID: 1600960
Sex: F
Age: 33
State: PA

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle weakness, ?it is like tired ? in the same arm of the injection; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Muscle weakness, ?it is like tired ? in the same arm of the injection) and INJECTION SITE PAIN (Soreness at the injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication. On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced MUSCULAR WEAKNESS (Muscle weakness, ?it is like tired ? in the same arm of the injection) and INJECTION SITE PAIN (Soreness at the injection site). At the time of the report, MUSCULAR WEAKNESS (Muscle weakness, ?it is like tired ? in the same arm of the injection) and INJECTION SITE PAIN (Soreness at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient received their first dose of Moderna vaccine on 26-Mar-2021 and since 27-Mar-2021 the patient experienced soreness at the injection site and also reported of experiencing muscle weakness, like tired, in the same arm of the injection. Reportedly, the patient tried to call their doctor, but their doctor was busy. Concomitant medication used by the patient also included anti depressive medication. No treatment information was provided.

Other Meds: VITAMIN B12 [VITAMIN B12 NOS]

Current Illness:

ID: 1600961
Sex: F
Age: 77
State: NY

Vax Date: 03/15/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Covid-arm; Itching; Rash; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid-arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE RASH (Rash) and VACCINATION SITE ERYTHEMA (Redness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included PARACETAMOL (TYLENOL) and VITAMINS NOS for an unknown indication. On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid-arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE RASH (Rash) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE REACTION (Covid-arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE RASH (Rash) and VACCINATION SITE ERYTHEMA (Redness) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient received their first dose of Moderna vaccine on 15-Mar-2021 and after 2 or 3 days from the shot, the patient experienced Covid-arm, redness, rash and itching on their vaccination arm. The Doctor prescribed steroids cream which the patient had been taking for 1 week twice per day. Reportedly, the reaction was still ongoing but not itching like it was. The patient still had little red and rash. The patient spoke with their doctor but didn't saw the doctor. The patient was under decongestion, Tylenol, and Vitamins. Concomitant medication used by the patient also included decongestion. Treatment medication prescribed to the patient included steroids cream.

Other Meds: TYLENOL; VITAMINS NOS

Current Illness:

ID: 1600962
Sex: F
Age: 36
State: CA

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She felt very dizzy; had diarrhea; Body Pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (She felt very dizzy), DIARRHOEA (had diarrhea), PAIN (Body Pain) and CHILLS (Chills) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DIZZINESS (She felt very dizzy), DIARRHOEA (had diarrhea), PAIN (Body Pain) and CHILLS (Chills). On 04-Mar-2021, DIZZINESS (She felt very dizzy) and DIARRHOEA (had diarrhea) had resolved. At the time of the report, PAIN (Body Pain) and CHILLS (Chills) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. No treatment was reported.

Other Meds:

Current Illness:

ID: 1600963
Sex: F
Age: 56
State: TX

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomited.; Headache; Nauseas; Arm only hurt if she pushed at the injection site; Pain in the arm of the injection( left arm) , could not lift her arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain in the arm of the injection( left arm) , could not lift her arm), INJECTION SITE PAIN (Arm only hurt if she pushed at the injection site), HEADACHE (Headache), NAUSEA (Nauseas) and VOMITING (Vomited.) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in January 2021. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced INJECTION SITE PAIN (Pain in the arm of the injection( left arm) , could not lift her arm). On 22-Mar-2021, the patient experienced INJECTION SITE PAIN (Arm only hurt if she pushed at the injection site). On 26-Mar-2021, the patient experienced HEADACHE (Headache) and NAUSEA (Nauseas). On 29-Mar-2021, the patient experienced VOMITING (Vomited.). On 21-Mar-2021, INJECTION SITE PAIN (Pain in the arm of the injection( left arm) , could not lift her arm) had resolved. At the time of the report, INJECTION SITE PAIN (Arm only hurt if she pushed at the injection site), HEADACHE (Headache), NAUSEA (Nauseas) and VOMITING (Vomited.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient received their first dose of the Moderna vaccine on 20-Mar-2021 and on that day the patient had pain in the arm of the injection. The patient was not able to lift their arm till 21-Mar-2021. On 22-Mar-2021, it was hurting only if they pushed at the injection site. On 26-Mar-2021, the patient began to have headache and added that the patient was not a person who has that kind of aches. The patient also experienced nauseas and on 29-Mar-2021, the patient vomited. The patient mentioned they had Covid on Jan-2021 and had this kind of headache. No Concomitant product use was reported. The patient had Acetaminophen and Tylenol on 20-Mar-2021 and on 28-Mar-2021, the patient began to take the medicine again.

Other Meds:

Current Illness:

ID: 1600964
Sex: F
Age:
State: LA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient don't speak too much; Received the second dose twice; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (Received the second dose twice) and SPEECH DISORDER (Patient don't speak too much) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced EXTRA DOSE ADMINISTERED (Received the second dose twice). On an unknown date, the patient experienced SPEECH DISORDER (Patient don't speak too much). On 30-Mar-2021, EXTRA DOSE ADMINISTERED (Received the second dose twice) had resolved. At the time of the report, SPEECH DISORDER (Patient don't speak too much) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The reporter said the patient received the second dose twice, once on the morning and again on the afternoon on 30-Mar-2021. The reporter mentioned that the they had a 24 hour caregiving service and the first caregiver brought the patient on the morning and the second caregiver on the afternoon. The reporter also mentioned the patient don't speak too much. Reportedly, the reporter was outside of the pharmacy. No Concomitant product use was reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.

Other Meds:

Current Illness:

ID: 1600965
Sex: F
Age:
State:

Vax Date: 03/18/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling lymph nodes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swelling lymph nodes). At the time of the report, LYMPHADENOPATHY (Swelling lymph nodes) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments. The patient received their first dose on 18-Mar-2021 and developed swelling of the lymph nodes. No Concomitant product use was reported. No treatment information was provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 679,999

Page last modified: 03 October 2021 5:28pm